{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:12:41Z","timestamp":1774552361292,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206065"],"award-info":[{"award-number":["H2024206065"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Research Project of Hebei Education Department","award":["BJ2025204"],"award-info":[{"award-number":["BJ2025204"]}]},{"name":"Medical Science Research Project of Hebei Provincial Health Commission","award":["20240133"],"award-info":[{"award-number":["20240133"]}]},{"name":"Medical Science Research Project of Hebei Provincial Health Commission","award":["20250194"],"award-info":[{"award-number":["20250194"]}]},{"name":"Shijiazhuang Science and Technology Research and Development Plan","award":["2412006103"],"award-info":[{"award-number":["2412006103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02883-6","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:28:26Z","timestamp":1754998106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of triglyceride-glucose-related indices with all-cause and cause-specific mortality in individuals with prediabetes"],"prefix":"10.1186","volume":"24","author":[{"given":"Liwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"Suppl 1","key":"2883_CR1","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"AD Association","year":"2020","unstructured":"Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14\u201331.","journal-title":"Diabetes Care"},{"issue":"7","key":"2883_CR2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/dc22-2376","volume":"46","author":"MR Rooney","year":"2023","unstructured":"Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46(7):1388\u201394.","journal-title":"Diabetes Care"},{"issue":"10","key":"2883_CR3","first-page":"Cd012661","volume":"10","author":"B Richter","year":"2018","unstructured":"Richter B, Hemmingsen B, Metzendorf MI, Takwoingi Y. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst Rev. 2018;10(10):Cd012661.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2883_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.33594\/000000282","volume":"54","author":"RB Nisr","year":"2020","unstructured":"Nisr RB, Shah DS, Hundal HS. Mono- and polyunsaturated fatty acids counter Palmitate-Induced mitochondrial dysfunction in rat skeletal muscle cells. Cell Physiol Biochem. 2020;54(5):975\u201393.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2883_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","volume":"5","author":"B Warren","year":"2017","unstructured":"Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities (ARIC) study. Lancet Diabetes Endocrinol. 2017;5(1):34\u201342.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2883_CR6","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.","journal-title":"BMJ"},{"issue":"11","key":"2883_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","volume":"57","author":"Y Huang","year":"2014","unstructured":"Huang Y, Cai X, Qiu M, Chen P, Tang H, Hu Y, et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 2014;57(11):2261\u20139.","journal-title":"Diabetologia"},{"issue":"9833","key":"2883_CR8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279\u201390.","journal-title":"Lancet"},{"issue":"8","key":"2883_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","volume":"18","author":"AE Brown","year":"2016","unstructured":"Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18(8):75.","journal-title":"Curr Cardiol Rep"},{"key":"2883_CR10","doi-asserted-by":"publisher","first-page":"600824","DOI":"10.3389\/fonc.2020.600824","volume":"10","author":"I Rahman","year":"2020","unstructured":"Rahman I, Athar MT, Islam M. Type 2 diabetes, obesity, and cancer share some common and critical pathways. Front Oncol. 2020;10:600824.","journal-title":"Front Oncol"},{"issue":"184","key":"2883_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.24976\/Discov.Med.202436184.81","volume":"36","author":"C Milionis","year":"2024","unstructured":"Milionis C, Koukkou E, Venaki E, Ilias I. Testosterone and glucose homeostasis in adult males: current insights and future prospects. Discov Med. 2024;36(184):865\u201373.","journal-title":"Discov Med"},{"issue":"6","key":"2883_CR12","doi-asserted-by":"publisher","first-page":"e7108","DOI":"10.1002\/cam4.7108","volume":"13","author":"H Wang","year":"2024","unstructured":"Wang H, Ruan S, Wu Z, Yan Q, Chen Y, Cui J, et al. Prognostic significance of glucose-lipid metabolic index in pancreatic cancer patients with diabetes mellitus. Cancer Med. 2024;13(6):e7108.","journal-title":"Cancer Med"},{"issue":"Suppl 2","key":"2883_CR13","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.2337\/dc08-s264","volume":"31","author":"MH Shanik","year":"2008","unstructured":"Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care. 2008;31(Suppl 2):S262\u2013268.","journal-title":"Diabetes Care"},{"issue":"4","key":"2883_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"2883_CR15","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2883_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"2883_CR17","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2883_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1521-690X(03)00042-3","volume":"17","author":"G Pacini","year":"2003","unstructured":"Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17(3):305\u201322.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2883_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pcd.2019.08.004","volume":"14","author":"P Chamroonkiadtikun","year":"2020","unstructured":"Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study. Prim Care Diabetes. 2020;14(2):161\u20137.","journal-title":"Prim Care Diabetes"},{"key":"2883_CR20","doi-asserted-by":"publisher","first-page":"109042","DOI":"10.1016\/j.diabres.2021.109042","volume":"180","author":"HM Park","year":"2021","unstructured":"Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180:109042.","journal-title":"Diabetes Res Clin Pract"},{"key":"2883_CR21","doi-asserted-by":"publisher","first-page":"1414402","DOI":"10.3389\/fendo.2024.1414402","volume":"15","author":"J Xiao","year":"2024","unstructured":"Xiao J, Zhou L, Luo C, Han Y, Huang Z. Non-linear relationship between TyG index and the risk of prediabetes in young people: a 5-year retrospective cohort study in Chinese young adults. Front Endocrinol (Lausanne). 2024;15:1414402.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2883_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s41043-023-00410-5","volume":"42","author":"M Sharafi","year":"2023","unstructured":"Sharafi M, Amiri Z, Pezeshki B, Mohsenpour MA, Eftekhari MH, Afrashteh S, et al. Predictive value of triglycerides to high-density lipoprotein cholesterol and triglyceride glycemic index for diabetes incidence in pre-diabetes patients: a prospective cohort study. J Health Popul Nutr. 2023;42(1):67.","journal-title":"J Health Popul Nutr"},{"issue":"8","key":"2883_CR23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2337\/dc18-1920","volume":"42","author":"K Park","year":"2019","unstructured":"Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569\u201373.","journal-title":"Diabetes Care"},{"issue":"1","key":"2883_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12944-023-01981-2","volume":"22","author":"A Kityo","year":"2023","unstructured":"Kityo A, Lee SA. Association of cardiometabolic factors and insulin resistance surrogates with mortality in participants from the Korean genome and epidemiology study. Lipids Health Dis. 2023;22(1):210.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2883_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 1","key":"2883_CR26","first-page":"S11","volume":"36","author":"Standards of medical care in diabetes","year":"2013","unstructured":"Standards of medical care in diabetes\u20132013. Diabetes Care. 2013;36(Suppl 1):S11\u201366.","journal-title":"Diabetes Care"},{"issue":"1","key":"2883_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12933-023-02041-w","volume":"22","author":"R Zheng","year":"2023","unstructured":"Zheng R, Qian S, Shi Y, Lou C, Xu H, Pan J. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):307.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2883_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-023-01737-3","volume":"22","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):10.","journal-title":"Cardiovasc Diabetol"},{"key":"2883_CR29","doi-asserted-by":"crossref","unstructured":"Lee YH, Han K, Yoon HE, Chung S, Sitapati AM, Hwang HS. Triglyceride-glucose index and risks of All-cause and Cause-specific mortality in young adults. J Clin Endocrinol Metab. 2025.","DOI":"10.1210\/clinem\/dgaf176"},{"issue":"1","key":"2883_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2883_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the united States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2883_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-024-02261-8","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D. The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged\u2009\u2264\u200965 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):168.","journal-title":"Cardiovasc Diabetol"},{"key":"2883_CR33","doi-asserted-by":"publisher","first-page":"m2297","DOI":"10.1136\/bmj.m2297","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.","journal-title":"BMJ"},{"issue":"1","key":"2883_CR34","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1186\/s12889-024-20551-4","volume":"24","author":"X Meng","year":"2024","unstructured":"Meng X, Wang X, Feng B, Zhao Z, Song Q, Xu W, et al. Association between triglyceride-glucose index and in-hospital all-cause mortality under different glucose metabolism status among patients with coronary artery disease. BMC Public Health. 2024;24(1):3051.","journal-title":"BMC Public Health"},{"issue":"1","key":"2883_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2883_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/met.2020.0092","volume":"19","author":"TH Raimi","year":"2021","unstructured":"Raimi TH, Dele-Ojo BF, Dada SA, Fadare JO, Ajayi DD, Ajayi EA, et al. Triglyceride-Glucose index and related parameters predicted metabolic syndrome in Nigerians. Metab Syndr Relat Disord. 2021;19(2):76\u201382.","journal-title":"Metab Syndr Relat Disord"},{"issue":"12","key":"2883_CR37","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s40618-021-01608-2","volume":"44","author":"M Mirr","year":"2021","unstructured":"Mirr M, Skrypnik D, Bogda\u0144ski P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831\u201343.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2883_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24(1):52.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2883_CR39","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.4239\/wjd.v16.i3.101488","volume":"16","author":"MJ Liu","year":"2025","unstructured":"Liu MJ, Pei JY, Zeng C, Xing Y, Zhang YF, Tang PQ, et al. Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients. World J Diabetes. 2025;16(3):101488.","journal-title":"World J Diabetes"},{"issue":"7","key":"2883_CR40","doi-asserted-by":"publisher","first-page":"110233","DOI":"10.1016\/j.isci.2024.110233","volume":"27","author":"J Ke","year":"2024","unstructured":"Ke J, Ruan X, Liu W, Liu X, Wu K, Qiu H, et al. Prospective cohort studies underscore the association of abnormal glycemic measures with all-cause and cause-specific mortalities. iScience. 2024;27(7):110233.","journal-title":"iScience"},{"issue":"1","key":"2883_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12944-025-02540-7","volume":"24","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Guo H, Sun Z, Zhang D, Lin Y, Huang L, et al. Associations of modified triglyceride-glucose indices and the triglyceride\/high-density lipoprotein ratio with all-cause and cause-specific mortality in the general population: an analysis of the UK biobank database. Lipids Health Dis. 2025;24(1):126.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2883_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-024-02120-6","volume":"23","author":"Y Yao","year":"2024","unstructured":"Yao Y, Wang B, Geng T, Chen J, Chen W, Li L. The association between TyG and all-cause\/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2883_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12944-025-02445-5","volume":"24","author":"E Xiao","year":"2025","unstructured":"Xiao E, Yu R, Cai X, Jiang L, Li J, Ma C, et al. Development and validation of a novel metabolic health-related nomogram to improve predictive performance of cardiovascular disease risk in patients with prediabetes. Lipids Health Dis. 2025;24(1):45.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2883_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2883_CR45","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808\u201329.","journal-title":"Circ Res"},{"issue":"7203","key":"2883_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"issue":"6917","key":"2883_CR47","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374.","journal-title":"Nature"},{"issue":"1","key":"2883_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2883_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12933-024-02396-8","volume":"23","author":"HM He","year":"2024","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Mu YK, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):307.","journal-title":"Cardiovasc Diabetol"},{"key":"2883_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fendo.2013.00071","volume":"4","author":"H Kwon","year":"2013","unstructured":"Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:71.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2883_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CM9.0000000000001263","volume":"134","author":"YX Xian","year":"2020","unstructured":"Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl). 2020;134(1):8\u201319.","journal-title":"Chin Med J (Engl)"},{"issue":"9976","key":"2883_CR52","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"J Fulcher","year":"2015","unstructured":"Fulcher J, O\u2019Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397\u2013405.","journal-title":"Lancet"},{"issue":"20","key":"2883_CR53","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557\u201365.","journal-title":"N Engl J Med"},{"issue":"2","key":"2883_CR54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2020.599","volume":"53","author":"GY Pih","year":"2021","unstructured":"Pih GY, Gong EJ, Choi JY, Kim MJ, Ahn JY, Choe J, et al. Associations of serum lipid level with gastric cancer risk, pathology, and prognosis. Cancer Res Treat. 2021;53(2):445\u201356.","journal-title":"Cancer Res Treat"},{"key":"2883_CR55","doi-asserted-by":"crossref","unstructured":"Wulaningsih W, Garmo H, Holmberg L, Hammar N, Jungner I, Walldius G et al. Serum lipids and the risk of gastrointestinal malignancies in the swedish AMORIS Study. J Cancer Epidemiol. 2012; 2012:792034.","DOI":"10.1155\/2012\/792034"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02883-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:12:09Z","timestamp":1756901529000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02883-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the NCHS Research Ethics Review Board (ERB). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}